Common Sequence Variants in Pharmacodynamic and Pharmacokinetic Pathway-Related Genes Conferring LDL Cholesterol Response to Statins

• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation106 , 3143–3421 (2002).
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA288 , 2998–3007 (2002).
   PubMed Web of Science ®Google Scholar
• Chasman DI , PosadaD, SubrahmanyanL, CookNR, StantonVP Jr, Ridker PM: Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA291 , 2821–2827 (2004).
   PubMed Web of Science ®Google Scholar
• Humphries SE , HingoraniA: Pharmacogenetics: progress, pitfalls and clinical potential for coronary heart disease.Vascul. Pharmacol.44 , 119–125 (2006).
   PubMed Web of Science ®Google Scholar
• Peters BJ , KlungelOH, de Boer A, Maitland-van der Zee AH: Genetic determinants of response to statins. Expert Rev. Cardiovasc. Ther.7 , 977–983 (2009).
   PubMedGoogle Scholar
• Ordovas JM , MooserV: Nutrigenomics and nutrigenetics.Curr. Opin. Lipidol.15 , 101–108 (2004).
   PubMed Web of Science ®Google Scholar
• Shastry BS : Genetic diversity and new therapeutic concepts.J. Hum. Genet.50 , 321–328 (2005).
   PubMed Web of Science ®Google Scholar
• Kajinami K , AkaoH, PoliseckiE, SchaeferEJ: Pharmacogenomics of statin responsiveness.Am. J. Cardiol.96 , K65–K70; discussion K34–K35 (2005).
   PubMed Web of Science ®Google Scholar
• Mangravite LM , ThornCF, KraussRM: Clinical implications of pharmacogenomics of statin treatment.Am. J. Cardiol.6 , 360–374 (2006).
   Google Scholar
• Schmitz G , LangmannT: Pharmacogenomics of cholesterol-lowering therapy.Vascul. Pharmacol.44 , 75–89 (2006).
   PubMed Web of Science ®Google Scholar
• Thompson JF Man M, Johnson KJ et al.: An association study of 43 SNPs in 16 candidate genes with atorvastatin response. Pharmacogenomics J.5 , 352–358 (2005).
   PubMed Web of Science ®Google Scholar
• Zineh I : Genetic polymorphisms and statin therapy.JAMA292 , 1302–1303 (2004).
   PubMed Web of Science ®Google Scholar
• Krauss RM , MangraviteLM, SmithJD et al.: Variation in the 3-hydroxyl-3-methylglutaryl coenzyme A reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment.Circulation117 , 1537–1544 (2008).
   PubMed Web of Science ®Google Scholar
• International HapMap Consortium: A haplotype map of the human genome. Nature437 , 1299–1320 (2005).
   PubMed Web of Science ®Google Scholar
• Schmitz G , A Schmitz-Madry, Ugocsai P: Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy. Curr. Opin. Lipidol.18 , 164–173 (2007).
   PubMed Web of Science ®Google Scholar
• Chien KL , FangWH, WenHC et al.: APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.Clin. Chim. Acta390 , 56–62 (2008).
   PubMed Web of Science ®Google Scholar
• Chien KL , HsuHC, SuTC, LeeYT: Consistency in genetic inheritance mode and heritability patterns of triglyceride vs. high density lipoprotein cholesterol ratio in two Taiwanese family samples.BMC Genet.4 , 7–16 (2003).
   PubMed Web of Science ®Google Scholar
• Kao JT , WenHC, ChienKL, HsuHC, LinSW: A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia.Hum. Mol. Genet.12 , 2533–2539 (2003).
   PubMed Web of Science ®Google Scholar
• Mangravite LM , KraussRM: Pharmacogenomics of statin response.Curr. Opin. Lipidol.18 , 409–414 (2007)
   PubMed Web of Science ®Google Scholar
• Kajinami K , BrousseauME, NartsuphaC, OrdovasJM, SchaeferEJ: ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin.J. Lipid Res.45 , 653–656 (2004).
   PubMed Web of Science ®Google Scholar
• Salah D , BohnetK, GueguenR, SiestG, VisvikisS: Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort.J. Lipid Res.38 , 904–912 (1997).
   PubMed Web of Science ®Google Scholar
• Kivisto KT , NiemiM, SchaeffelerE et al.: Lipid-lowering response to statins is affected by CYP3A5 polymorphism.Pharmacogenetics14 , 523–525 (2004).
   PubMedGoogle Scholar
• Kajinami K , BrousseauME, OrdovasJM, SchaeferEJ: CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia.Am. J. Cardiol.93 , 104–107 (2004).
   PubMed Web of Science ®Google Scholar
• Vermes A , VermesI: Genetic polymorphisms in cytochrome P450 enzymes: effect on efficacy and tolerability of HMG-CoA reductase inhibitors.Am. J. Cardiovasc. Drugs4 , 247–255 (2004).
   PubMedGoogle Scholar
• Chien KL , HsuHC, SuTC, ChenMF, LeeYT, HuFB: Apolipoprotein B and non-high-density lipoprotein cholesterol and risk of coronary heart disease in Chinese.J. Lipid Res.48 , 2499–2505 (2007).
   PubMed Web of Science ®Google Scholar
• Hommel G : A Comparison of two modified Bonferroni procedures.Biometrika75 , 383–386 (1988).
   Web of Science ®Google Scholar
• Benjamini Y , HochbergY: Controlling the false discovery rate: a practical and powerful approach to multiple testing.J. R. Statist. Soc. B57 , 289–300 (1995).
   Web of Science ®Google Scholar
• Zhao JH , CurtisD, ShamPC: Model-free analysis and permutation tests for allelic associations.Hum. Hered.50 , 133–139 (2000).
   PubMed Web of Science ®Google Scholar
• Tregouet DA , EscolanoS, TiretL, MalletA, GolmardJL: A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm.Ann. Hum. Genet.68 , 165–177 (2004).
   PubMed Web of Science ®Google Scholar
• Lewontin RC : On measures of gametic disequilibrium.Genetics120 , 849–852 (1988).
   PubMed Web of Science ®Google Scholar
• Devlin B , RischN: A comparison of linkage disequilibrium measures for fine-scale mapping.Genomics29 , 311–322 (1995).
   PubMed Web of Science ®Google Scholar
• Gauderman WJ : Sample size requirements for association studies of gene–gene interaction.Am. J. Epidemiol.155 , 478–484 (2002).
   PubMed Web of Science ®Google Scholar
• Salazar LA , HirataMH, QuintaoEC, HirataRD: Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia.J. Clin. Lab. Anal.14 , 125–131 (2000).
   PubMed Web of Science ®Google Scholar
• Burkhardt R , KennyEE, LoweJK et al.: Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon 13.Arterioscler. Thromb. Vasc. Biol.28 , 2078–2084 (2008).
   PubMed Web of Science ®Google Scholar
• Medina MW , GaoF, RuanW, RotterJI, KraussRM: Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin.Circulation118 , 355–362 (2008).
   PubMed Web of Science ®Google Scholar
• Spence JT , KoudelkaAP, Tseng-CrankJC: Role of protein synthesis in the carbohydrate-induced changes in the activities of acetyl-CoA carboxylase and hydroxymethylglutaryl-CoA reductase in cultured rat hepatocytes.Biochem. J.227 , 939–947 (1985).
   PubMed Web of Science ®Google Scholar
• Fiegenbaum M , SilveiraFR, van der Sand CR et al.: Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes. Pharmacogenomics J.5 , 359–364 (2005).
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature447 , 661–678 (2007).
   PubMed Web of Science ®Google Scholar
• Miltiadous G , SaougosV, CariolouM, ElisafMS: Plasma lipoprotein(a) levels and ldl-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.Ann. Clin. Lab. Sci.36 , 353–355 (2006).
   PubMed Web of Science ®Google Scholar

▪ Websites

• International HapMap Project 92006 www.hapmap.org (Accessed 10November2009)
   Google Scholar